Who owns CAI?
Institutional ownership of Caris Life Sciences Inc. from Form 13F, Q2 2026
246 institutional managers reported holding Caris Life Sciences Inc. (CAI) in Form 13F filings for Q2 2026, with 154,105,427 shares worth $2.7B. The largest reported holder was FMR LLC. Managers that filed both quarters cut a net 2,763,234 shares (-1.8%). 68 opened new positions and 24 sold out.
- Funds holding
- 246
- Value held
- $2.7B
- New / sold out
- 68 / 24
- Net shares, same filers
- -1.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CAI
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $551M | 20.1% | 30,923,878 | Added |
| J. H. Whitney Equity Partners VI, LLC | $201M | 7.3% | 11,256,615 | Trimmed |
| Coatue Management LLC | $175M | 6.4% | 9,819,992 | Unchanged |
| Braidwell LP | $147M | 5.4% | 8,256,032 | Added |
| Sixth Street Partners Management Company, L.P. | $131M | 4.8% | 7,327,041 | Trimmed |
| PointState Capital LP | $122M | 4.4% | 6,828,835 | Trimmed |
| JPMorgan Chase & Co | $120M | 4.3% | 6,558,514 | Added |
| BlackRock, Inc. | $98.7M | 3.6% | 5,536,798 | Added |
| T. Rowe Price Investment Management, Inc. | $90.5M | 3.3% | 5,079,141 | Trimmed |
| Vanguard Portfolio Management LLC | $86.3M | 3.1% | 4,844,431 | Added |
| Vanguard Capital Management LLC | $76.3M | 2.8% | 4,280,238 | Added |
| Los Angeles Capital Management LLC | $70.5M | 2.6% | 3,958,531 | Added |
| Neuberger Berman Group LLC | $64.0M | 2.3% | 3,590,963 | Unchanged |
| Orbimed Advisors LLC | $50.0M | 1.8% | 2,806,811 | Unchanged |
| BNP Paribas Financial Markets | $42.2M | 1.5% | 2,370,268 | Added |
| Millennium Management LLC | $39.3M | 1.4% | 2,202,647 | Added |
| Mak Capital One LLC | $34.5M | 1.3% | 1,937,229 | New |
| Morgan Stanley | $34.5M | 1.3% | 1,935,531 | Added |
| Duquesne Family Office LLC | $33.8M | 1.2% | 1,894,450 | Unchanged |
| Clearbridge Investments, LLC | $28.4M | 1.0% | 1,595,877 | Added |
| FIL Ltd | $27.6M | 1.0% | 1,548,918 | Added |
| UBS Group AG | $25.4M | 0.9% | 1,423,371 | Trimmed |
| HRT Financial LP | $25.3M | 0.9% | 1,418,392 | New |
| Canada Pension Plan Investment Board | $24.5M | 0.9% | 1,374,952 | Added |
| State Street Corp | $21.7M | 0.8% | 1,217,548 | Added |
Share of 13F holdings is each fund's shares as a share of the 154,105,427 CAI shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- JPMorgan Chase & Co Added+$56.8M
- Mak Capital One LLC New+$34.5M
- Los Angeles Capital Management LLC Added+$29.7M
- HRT Financial LP New+$25.3M
- Amundi Added+$21.3M
- Vanguard Portfolio Management LLC Added+$19.4M
- Vanguard Capital Management LLC Added+$17.0M
- Morgan Stanley Added+$15.3M
- BNP Paribas Financial Markets Added+$13.5M
- BlackRock, Inc. Added+$12.1M
Biggest sellers in Q2 2026
- Sixth Street Partners Management Company, L.P. Trimmed-$126M
- J. H. Whitney Equity Partners VI, LLC Trimmed-$125M
- Price T Rowe Associates Inc Trimmed-$56.4M
- UBS Group AG Trimmed-$23.6M
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trimmed-$20.5M
- Invesco Ltd. Trimmed-$19.4M
- Point72 Asset Management, L.P. Sold out-$16.4M
- Gotham Asset Management, LLC Trimmed-$11.7M
- PointState Capital LP Trimmed-$9.5M
- T. Rowe Price Investment Management, Inc. Trimmed-$9.1M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $416M and sold $464M; 104 added and 47 trimmed.
Schedule 13D and 13G filings on CAI
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-02-05FMR LLC SCHEDULE 13G filed by Caris Life Sciences Inc.Schedule 13G
- 2025-08-14J H Whitney VI L P SCHEDULE 13G filed by Caris Life Sciences Inc.Schedule 13G
- 2025-08-13HALBERT DAVID D SCHEDULE 13G filed by Caris Life Sciences Inc.Schedule 13G
- 2025-07-28TSSP Sub-Fund HoldCo LLC SCHEDULE 13G filed by Caris Life Sciences Inc.Schedule 13G
- 2025-06-24RIVERVIEW GROUP LLC SCHEDULE 13G filed by Caris Life Sciences Inc.Schedule 13G
Questions about CAI ownership
- Who owns CAI stock?
- 246 institutional investment managers reported CAI positions in their Form 13F filings for Q2 2026, holding 154,105,427 shares worth $2.7B in total. FMR LLC reported the largest position.
- Are funds buying or selling CAI?
- In Q2 2026, 68 managers opened new CAI positions, 104 added, 47 trimmed and 24 sold out. Managers that filed in both quarters sold a net 2,763,234 shares.
- How current is this CAI institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CAI by CUSIP. Options are left out. CAI news and filings · CAI insider trades · Top funds